Czibere Akos
Chief Medical Officer
Sale 10b5-1
- Shares
- 7,401
- Price
- $21.03
- Value
- $155,648
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•30 filings
AKTS
Aktis Oncology, Inc.
Net sales of $258.6K over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$258,621
0 buyers · 1 sellers
12-month purchases
$114,311,628
17 distinct insiders
12-month sales
$3,231,412
3 distinct insiders
Highlighted alerts
18
2 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get AKTS insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
AKTS overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
76
Raw transactions
Everything returned by the filing
20
Voluntary view
P/S trades after deterministic checks
13
Administrative noise
Stored, never alerted
4
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 12,500
- Price
- $4.95
- Footnotes
- 4
The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2026. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.6700 to $20.6500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.6700 to $21.5000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 25% of the original number of shares subject to the option vested on July 1, 2025, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Czibere Akos
Chief Medical Officer
Sale 10b5-1
- Shares
- 5,099
- Price
- $20.19
- Value
- $102,973
Herrmann Ken
Director
SaleAlert
- Shares
- 1,350
- Price
- $24.56
- Value
- $33,159
Herrmann Ken
Director
SaleAlert
- Shares
- 3,506
- Price
- $24.56
- Value
- $86,115
Herrmann Ken
Director
SaleAlert
- Shares
- 3,065
- Price
- $25.21
- Value
- $77,259
Ron-Bigger Shulamit
Chief Operating Officer
SaleAlert
- Shares
- 4,200
- Price
- $28.75
- Value
- $120,740
Ron-Bigger Shulamit
Chief Operating Officer
SaleAlert
- Shares
- 30,000
- Price
- $27.94
- Value
- $838,137
Ron-Bigger Shulamit
Chief Operating Officer
SaleAlert
- Shares
- 15,800
- Price
- $27.13
- Value
- $428,681
Czibere Akos
Chief Medical Officer
SaleAlert
- Shares
- 4,371
- Price
- $28.71
- Value
- $125,482
Czibere Akos
Chief Medical Officer
SaleAlert
- Shares
- 30,829
- Price
- $27.95
- Value
- $861,735
Czibere Akos
Chief Medical Officer
SaleAlert
- Shares
- 14,800
- Price
- $27.13
- Value
- $401,484
Foley Todd
Director
PurchaseAlert
- Shares
- 232,870
- Price
- $18.00
- Value
- $4,191,660
MPM BIOVENTURES 2018, L.P.
10% owner
PurchaseAlert
- Shares
- 1,112,777
- Price
- $18.00
- Value
- $20,029,986
GADICKE ANSBERT
10% owner
PurchaseAlert
- Shares
- 1,112,777
- Price
- $18.00
- Value
- $20,029,986
Vida Ventures II, LLC
10% owner
PurchaseAlert
- Shares
- 22,545
- Price
- $18.00
- Value
- $405,810
Vida Ventures II, LLC
10% owner
PurchaseAlert
- Shares
- 812,455
- Price
- $18.00
- Value
- $14,624,190
Kim Helen Susan
Director
PurchaseAlert
- Shares
- 22,545
- Price
- $18.00
- Value
- $405,810
Kim Helen Susan
Director
PurchaseAlert
- Shares
- 812,455
- Price
- $18.00
- Value
- $14,624,190
EcoR1 Capital, LLC
Director
PurchaseAlert
- Shares
- 144,443
- Price
- $18.00
- Value
- $2,599,974
EcoR1 Capital, LLC
Director
PurchaseAlert
- Shares
- 2,077,779
- Price
- $18.00
- Value
- $37,400,022
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Czibere Akos Chief Medical Officer | Sale | 7,401 | $21.03 | $155,648 | |
| Sep 23, 2026 | Czibere Akos Chief Medical Officer | Sale | 5,099 | $20.19 | $102,973 | |
| Jul 20, 2026 | Herrmann Ken Director | Sale | 1,350 | $24.56 | $33,159 | |
| Jul 20, 2026 | Herrmann Ken Director | Sale | 3,506 | $24.56 | $86,115 | |
| Jul 17, 2026 | Herrmann Ken Director | Sale | 3,065 | $25.21 | $77,259 | |
| Jul 08, 2026 | Ron-Bigger Shulamit Chief Operating Officer | Sale | 4,200 | $28.75 | $120,740 | |
| Jul 08, 2026 | Ron-Bigger Shulamit Chief Operating Officer | Sale | 30,000 | $27.94 | $838,137 | |
| Jul 08, 2026 | Ron-Bigger Shulamit Chief Operating Officer | Sale | 15,800 | $27.13 | $428,681 | |
| Jul 08, 2026 | Czibere Akos Chief Medical Officer | Sale | 4,371 | $28.71 | $125,482 | |
| Jul 08, 2026 | Czibere Akos Chief Medical Officer | Sale | 30,829 | $27.95 | $861,735 | |
| Jul 08, 2026 | Czibere Akos Chief Medical Officer | Sale | 14,800 | $27.13 | $401,484 | |
| Jan 12, 2026 | Foley Todd Director | Purchase | 232,870 | $18.00 | $4,191,660 | |
| Jan 12, 2026 | MPM BIOVENTURES 2018, L.P. 10% owner | Purchase | 1,112,777 | $18.00 | $20,029,986 | |
| Jan 12, 2026 | GADICKE ANSBERT 10% owner | Purchase | 1,112,777 | $18.00 | $20,029,986 | |
| Jan 12, 2026 | Vida Ventures II, LLC 10% owner | Purchase | 22,545 | $18.00 | $405,810 | |
| Jan 12, 2026 | Vida Ventures II, LLC 10% owner | Purchase | 812,455 | $18.00 | $14,624,190 | |
| Jan 12, 2026 | Kim Helen Susan Director | Purchase | 22,545 | $18.00 | $405,810 | |
| Jan 12, 2026 | Kim Helen Susan Director | Purchase | 812,455 | $18.00 | $14,624,190 | |
| Jan 12, 2026 | EcoR1 Capital, LLC Director | Purchase | 144,443 | $18.00 | $2,599,974 | |
| Jan 12, 2026 | EcoR1 Capital, LLC Director | Purchase | 2,077,779 | $18.00 | $37,400,022 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.